From: Clinical spectrum and long-term outcomes of mpox: a cohort study spanning from acute infection to six-month follow-up
HIV status
N
Complications
No Complications
Risk ratio (95%-CI), p1
n
(%)
Total sample
43
20
(46.5)
23
(53.5)
HIV-negative
33
13
(39.4)
(60.6)
Reference
HIV-positive
10
7
(70.0)
3
(30.0)
1.78 (0.99–3.19), p = 0.109